Skip to main content
. 2023 Nov 20;12(2):1180–1188. doi: 10.1002/fsn3.3833

TABLE 2.

Thyroid function tests, baseline, and 3 months of post‐intervention.

Group Before intervention After intervention Test value/p
Median (min‐max) Median (min‐max) z p
TSH (uIU/mL) Control group 2.51 (1.99–4.60) 2.56 (2.46–4.40) −1.07 .28
MD 1.75 (1.25–2.76) 2.10 (1.21–2.83) −0.76 .44
GFD 1.26 (1.05–1.76) 1.47 (1.26–1.90) −1.17 .24
MGFD 1.65 (0.93–3.71) 1.92 (0.96–3.97) −1.78 .07
X 2 = 5.20 p = .16 X 2 = 8.32 p = .04 Difference = 3 < 1
FT3 (pg/mL) Control group 2.99 (2.80–3.87) 3.03 (2.90–3.88) −1.24 .21
MD 2.50 (2.45–2.70) 2.86 (2.78–2.94) −2.80 .01
GFD 2.60 (2.46–2.67) 2.71 (2.61–2.93) −2.19 .03
MGFD 3.30 (2.98–3.50) 3.57 (3.21–3.67) −2.80 .01
X 2 = 18.76 p = .00 Difference = 2.3 < 1.4 X 2 = 12.96 p = .00 Difference = 3 < 1.4
FT4 (ng/dL) Control group 14.06 (0.95–15.80) 14.50 (0.98–16.60) −2.70 .01
MD 0.91 (0.90–0.94) 0.97 (0.93–0.98) −2.44 .01
GFD 0.97 (0.88–1.04) 0.99 (0.98–1.28) −2.09 .04
MGFD 1.01 (0.94–1.30) 1.25 (0.98–1.54) −2.80 .01
X 2 = 7,11 p = .07 X 2 = 8.80 p = .03
Anti TPO (IU/mL) Control group 61.05 (36.11–76.67) 59.55 (30.67–76.90) −1.27 .20
MD 70.76 (47.88–102.30) 68.95 (46.32–90.80) −2.80 .01
GFD 150.29 (44.68–267.55) 133.25 (42.41–247.30) −2.70 .01
MGFD 257.56 (90.30–386.31) 140.20 (82.40–320.10) −2.80 .01
X 2 = 6.97 p = .07 X 2 = 5.53 p = .14
Anti Tg (IU/mL) Control group 22.85 (21.44–23.30) 21.65 (19.80–31.20) −0.05 .96
MD 20.00 (8.96–52.37) 13.74 (6.89–50.80) −2.80 .01
GFD 7.50 (2.05–56.70) 6.31 (2.03–40.47) −2.80 .01
MGFD 32.66 (19.87–46.50) 25.77 (15.60–43.20) −2.80 .01
X 2 = 4.32 p = .23 X 2 = 3.50 p = .32

Abbreviations: GFD,Gluten‐free diet; MD, Mediterranean diet; MGFD, Mediterranean gluten‐free diet; X 2, Ki square, Krukal Wallis‐H; z,Wilcoxon test.